时间标签：数据日期 2026-10-31 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/28–2026/10/31 ｜ 情报发生日期 2026-10-31
研究问题
However, detection of an abnormality before a threshold is reached does not establish that it predicts future sarcopenia or that acting on it improves outcomes (–).
方法
It organizes what candidate measurements assess, what study designs support them, and what validation is still required (–).；Its intended clinical focus is older adults, generally aged 65 years or above; evidence from other age groups is retained when relevant to mechanisms or life-course context, rather than treated as directly generalizable.；It is not a set of retrospectively reconstructed search strings or prespecified eligibility criteria.
核心结论
Current diagnostic thresholds are essential clinical anchors, but they are not primarily designed to detect the earliest biological alterations associated with muscle decline (–).；Neuromuscular remodeling, altered tissue composition, and metabolic or inflammatory disturbances may be detectable before an individual meets a conventional definition.；However, detection of an abnormality before a threshold is reached does not establish that it predicts future sarcopenia or that acting on it improves outcomes (–). ‖ 结论：Until those requirements are met, investigational measurements should support research and clinically indicated differential assessment, not unvalidated preclinical labeling or biomarker-directed treatment allocation.
局限
Incident sarcopenia must be distinguished from worsening strength, mobility limitation, falls, and other outcomes.；Demonstrating a cross-sectional association or an association with mortality does not by itself establish prediction of incident sarcopenia.；Models should show incremental value over simple clinical predictors and should not use measurements that effectively reproduce the reference definition without acknowledging this limitation.
对本项目的价值
★☆☆☆☆ 衰弱/肌少症是少有的已有监管认可终点的老年综合征，是临床转化的最短路径。
全文来源
PMC JATS 全文（正文 35,169 字符，已过标题/DOI 逐字归属校验）
原文题录
- 英文标题：A research framework for evaluating upstream multimodal sarcopenia risk domains in older adults.
- 期刊与标识：Front Med (Lausanne) · PMID 42953499 · DOI 10.3389/fmed.2026.1928432
C 级证据分级：C 级（预印本 / 观点评论，非原始研究）
本文属观点/评论类文献，不是原始研究。其论点依赖于作者对既有证据的梳理与判断，不构成新的实验证据。本站标注 C 级即为此意——阅读时请把它当作「领域内的思考框架」，而非「研究发现」。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。